Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis

Abstract Background A quantitative measurement of serum proteome biomarkers that would associate with disease progression endpoints can provide risk stratification for persons with multiple sclerosis (PwMS) and supplement the clinical decision‐making process. Materials and Methods In total, 202 PwMS...

Popoln opis

Bibliografske podrobnosti
Main Authors: Kian Jalaleddini, Dejan Jakimovski, Anisha Keshavan, Shannon McCurdy, Kelly Leyden, Ferhan Qureshi, Atiyeh Ghoreyshi, Niels Bergsland, Michael G. Dwyer, Murali Ramanathan, Bianca Weinstock‐Guttman, Ralph HB Benedict, Robert Zivadinov
Format: Article
Jezik:English
Izdano: Wiley 2024-03-01
Serija:Annals of Clinical and Translational Neurology
Online dostop:https://doi.org/10.1002/acn3.51996